Comparison of HepG2 feeder cells generated by exposure to γ-rays, X-rays, UV-C light or mitomycin C for ability to activate 7,12-dimethylbenz[a]anthracene in a cell-mediated Chinese hamster V79/HGPRT mutation assay

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 423, Issue 1-2, 1999, Pages 137-148

  Schrader, T J ^a  

^a TOXICOLOGY RESEARCH DIVISION   (Canada)

Author keywords

Activation; DMBA; HepG2; HGPRT; Mutagenesis; V79

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; AROCLOR 1254; ETHOXYRESORUFIN DEETHYLASE; MITOMYCIN C;

ANIMAL CELL; ARTICLE; ASSAY; CELL STRAIN HEPG2; CELL STRAIN V 79; COMPARATIVE STUDY; CONTROLLED STUDY; GAMMA RADIATION; HEPATOMA CELL; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION MUTAGENESIS; ULTRAVIOLET C RADIATION; X RAY;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; BIOTRANSFORMATION; CARCINOMA, HEPATOCELLULAR; COCULTURE TECHNIQUES; CRICETINAE; CRICETULUS; FIBROBLASTS; GAMMA RAYS; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LUNG; MITOMYCIN; MUTAGENICITY TESTS; TUMOR CELLS, CULTURED; ULTRAVIOLET RAYS; X-RAYS;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS;

EID: 0033601811     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(98)00235-8     Document Type: Article

References (45)

1. Langenbach R., Freed H.J., Huberman E. Liver cell-mediated mutagenesis of mammalian cells by liver carcinogens. Proc. Natl. Acad. Sci. U.S.A. 75:1978;2864-2867.
2. Langenbach R., Malick L., Nesnow S. Rat bladder cell-mediated mutagenesis of Chinese hamster V79 cells and metabolism of benzo[a]pyrene. J. Natl. Cancer Inst. 66:1981;913-917.
3. Rogers C.G., Nayak B.N., Heroux-Metcalf C. Lack of induction of sister chromatid exchanges and mutation of 6-thioguanine resistance in V79 cells by butylated hydroxyanisole with and without activation by rat or hamster hepatocytes. Cancer Lett. 27:1985;61-69.
4. Rogers C.G., Boyes B.G., Matula T.I., Heroux-Metcalf C., Clayson D.B. A case report: a multiple end-point approach to evaluation of cytotoxicity and genotoxicity of erythrosine (FD and C Red No. 3) in a V79 hepatocyte-mediated mutation assay. Mutat. Res. 205:1988;415-423.
5. Rogers C.G., Boyes B.G., Lok E. Comparative genotoxicity of 3 procarcinogens in V79 cells as related to glutathione S-transferase activity of hepatocytes from untreated rats and those fed 2% butylated hydroxyanisole. Mutat. Res. 244:1990;163-171.
6. L Dearfield K., Jacobson-Kram D., Brown N.A., Williams J.R. Evaluation of a human hepatoma cell line as a target cell in genetic toxicology. Mutat. Res. 108:1983;437-449.
7. Zhuo Z., Casciano D.A., Heflich R.H. Use of the human liver cell line Hep G2 in a modified Salmonella reversion assay. Cancer Lett. 32:1986;327-334.
8. Eddy E.P., Howard P.C., McCoy G.D., Rosenkranz H.S. Mutagenicity, unscheduled DNA synthesis, and metabolism of 1-nitropyrene in the human hepatoma cell line HepG2. Cancer Res. 47:1987;3163-3168.
9. Bhatt T.S., Coombs M., DiGiovanni J., Diamond L. Mutagenesis in Chinese hamster cells by cyclopenta(a)phenanthrenes activated by a human hepatoma cell line. Cancer Res. 43:1983;984-986.
10. Cahill A., White I.N.H. Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines. Carcinogenesis. 11:1990;1407-1411.
11. Natarajan A.T., Darroudi F. Use of human hepatoma cells for in vitro metabolic activation of chemical mutagens/carcinogens. Mutagenesis. 6:1991;399-403.
12. Darroudi F., Natarajan A.T. Metabolic activation of chemicals to mutagenic carcinogens by human hepatoma microsomal extracts in Chinese hamster ovary cells (in vitro). Mutagenesis. 8:1993;11-15.
13. Duverger-van Bogaert M., Dierickx P.J., Stecca C., Crutzen M.C. Metabolic activation by a supernatant from human hepatoma cells: a possible alternative in mutagenic tests. Mutat. Res. 292:1993;199-204.
14. M Hasspieler B., Alipour M., Naji-Ali F., Haffner G.D., Adeli K. Correlation between xenobiotic-mediated DNA damage and DNA repair in a human hepatoma cell line. Environ. Mol. Mutagen. 23(Suppl. 23):1994;24.
15. Naji-Ali F., Hasspieler B.M., Haffner D., Adeli K. Human bioassays to assess environmental genotoxicity: development of a DNA repair assay in HepG2 cells. Clin. Biochem. 27:1994;441-448.
16. Duverger-van Bogaert M., Dierickx P.J., Crutzen M.C. Mutagenic activation of aromatic amines by a human hepatoma cell (HepG2) supernatant tested by means of Salmonella typhimurium strains with different acetyltransferase activities. Mutat. Res. 335:1995;219-227.
17. Schrader T.J., Boyes B.G., Matula T.I., Héroux-Metcalf C., Langlois I., Downie R.H. In vitro investigation of toxaphene genotoxicity in S. typhimurium and Chinese hamster V79 lung fibroblasts. Mutat. Res. 413:1998;159-168.
18. Fisher H.W., Puck T.T. On the functions of X-irradiated feeder cells in supporting growth of single mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 42:1956;900-906.
19. Macpherson I., Bryden A. Mitomycin C treated cells as feeders. Exp. Cell Res. 69:1971;240-241.
20. Davies M.J., Lovell D.P., Anderson D. Thioguanine-resistant mutant frequency in T-lymphocytes from a healthy human population. Mutat. Res. 265:1992;165-171.
21. Burke M.D., Thompson S., Elcombe C.R., Halpert J., Haaparanta T., Mayer R.T. Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem. Pharmacol. 34:1985;3337-3345.
22. Kennedy S.W., Lorenzen A., James C.A., Collins B.T. Ethoxyresorufin-O-deethylase and porphyrin analysis in chicken embryo hepatocyte cultures with a fluorescence multiwell plate reader. Anal. Biochem. 211:1993;102-112.
23. Burke M.D., Thompson S., Weaver R.J., Wolf C.R., Mayer R.T. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem. Pharmacol. 48:1994;923-936.
24. Huberman E., Sachs L. Cell-mediated mutagenesis of mammalian cells with chemical carcinogens. Int. J. Cancer. 13:1974;326-333.
25. Lau H.H.S., Coffing S.L., Lee H., Harvey R.G., Baird W.M. Stereoselectivity of activation of 7,12-dimethylbenz[a]anthracene-3,4-dihydrodiol to the anti-diol epoxide metabolite in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay. Chem. Res. Toxicol. 8:1995;970-978.
26. Rogers C.G., Héroux-Metcalf C. Cytotoxicity and absence of mutagenic activity of vomitoxin (4-deoxy-nivalenol) in an hepatocyte-mediated mutation assay with V79 Chinese hamster lung cells. Cancer Lett. 20:1983;29-35.
27. Glatt H., Bartsch I., Christoph S., Coughtrie M.W., Falany C.N., Hagen M., Landsiedel R., Pabel U., Phillips D.H., Seidel A., Yamazoe Y. Sulfotransferase-mediated activation of mutagens studied using heterologous expression systems. Chem. Biol. Interact. 109:1998;195-219.
28. Yamakage K., Kusakabe H., Tanaka N. Comparative studies of MCL-5 cells and human lymphocytes for detecting indirect-acting clastogens. Mutat. Res. 412:1998;55-61.
29. 1-induced DNA adduct formation and p53 mutations in CYP450-expressing human liver cell lines. Carcinogenesis. 18:1997;1291-1297.
30. Sasaki J.C., Arey J., Eastmond D.A., Parks K.K., Grosovsky A.J. Genotoxicity induced in human lymphoblasts by atmospheric reaction products of naphthalene and phenanthrene. Mutat. Res. 393:1997;23-35.
31. Henstler J.G., Hengst A., Fuchs J., Tanner B., Pohl J., Oesch F. Induction of DNA crosslinks and DNA strand lesions by cyclophosphamide after activation by cytochrome P450 2B1. Mutat. Res. 373:1997;215-223.
32. Schmalix W.A., Lang D., Schneider A., Bocker R., Greim H., Doehmer J. Stable expression and coexpression of human cytochrome P450 oxidoreductase and cytochrome P450 1A2 in V79 Chinese hamster cells: sensitivity to quinones and biotransformation of 7-alkoxyresorufins and triazines. Drug Metab. Dispos. 24:1996;1314-1319.
33. Rueff J., Chiapella C., Chipman J.K., Darroudi F., Silva I.D., Duverger-van Bogaert M., Fonti E., Glatt H.R., Isern P., Laires A., Leonard A., Llagostera M., Mossesso P., Natarajan A.T., Palitti F., Rodrigues A.S., Schinoppi A., Turchi G., Werle-Schneider G. Development and validation of alternative metabolic systems for mutagenicity testing in short-term assays. Mutat. Res. 353:1996;151-176.
34. Crespi C.L., Gonzalez F.J., Steimel D.T., Turner T.R., Gelboin H.V., Penman B.W. Langenbach, a metabolically competent human cell line expressing five cDNAs encoding procarcinogen-activating enzymes: application to mutagenicity testing. Chem. Res. Toxicol. 4:1991;566-572.
35. Dawson J.R., Adans D.J., Wolf C.R. Induction of drug metabolizing enzymes in human liver cell line HepG2. FEBS. 183:1985;219-222.
36. Sassa S., Sugita O., Galbraith R.A., Kappas A. Drug metabolism by the human hepatoma cell, HepG2. Biochem. Biophys. Res. Commun. 143:1987;52-57.
37. Grant M.H., Duthie S.J., Gray A.G., Burke M.D. Mixed function oxidase and UDP-glucuronyltransferase activities in the human HepG2 hepatoma cell line. Bochem. Pharmacol. 37:1988;4111-4116.
38. Duthie S.J., Grant M.H. The role of reductive and oxidative metabolism in the toxicity of mitoxantrone, adriamycin and menadione in human liver derived HepG2 hepatoma cells. Br. J. Cancer. 60:1989;566-571.
39. Duthie S.J., Grant M.H. The toxicity of menadione and mitozantrone in human liver-derived Hep G2 hepatoma cells. Biochem. Pharmacol. 38:1989;1247-1255.
40. Doostdar H., Demoz A., Burke M.D., Melvin W.T., Grant M.H. Variation in drug-metabolizing enzyme activities during the growth of human Hep G2 hepatoma cells. Xenobiotica. 20:1990;435-441.
41. Doostdar H., Burke M.D., Melvin W.T., Grant M.H. The effects of dimethylsulphoxide and 5-aminolaevulinic acid on the activities of cytochrome P450-dependent mixed function oxidase and UDP-glucuronosyl transferase activities in human Hep G2 hepatoma cells. Biochem. Pharmacol. 42:1991;1307-1313.
42. Shwed J.A., Walle U.K., Walle T. Hep G2 cell line as a human model for sulphate conjugation of drugs. Xenobiotica. 22:1992;973-982.
43. Doostdar H., Grant M.H., Melvin W.T., Wolf C.R., Burke M.D. The effects of inducing agents on cytochrome P450 and UDP-glucuronyltransferase activities in human HepG2 hepatoma cells. Biochem. Pharmacol. 46:1993;629-635.
44. Nakama A., Kuroda K., Yamada A. Induction of cytochrome P450-dependent monooxygenase in serum-free cultured Hep G2 cells. Biochem. Pharmacol. 50:1995;1407-1412.
45. Guengerich F.P. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chem. Res. Toxicol. 4:1991;391-405.